Molecular Basis and Current Treatment for Alcoholic Liver Disease

被引:69
作者
Miranda-Mendez, Alejandra [1 ]
Lugo-Baruqui, Alejandro [1 ,2 ]
Armendariz-Borunda, Juan [1 ,2 ]
机构
[1] Univ Guadalajara, Inst Mol Biol Med & Gene Therapy, Guadalajara 44281, Jalisco, Mexico
[2] OPD Hosp Civil Guadalajara, Guadalajara 44340, Jalisco, Mexico
关键词
alcohol; alcoholism; fibrosis; cirrhosis; alcoholic liver disease; HEPATIC-ENCEPHALOPATHY; OXIDATIVE STRESS; RECEPTOR GENE; FATTY LIVER; ETHANOL; DEPENDENCE; STEATOSIS; INJURY; CELLS; TRANSPLANTATION;
D O I
10.3390/ijerph7051872
中图分类号
X [环境科学、安全科学];
学科分类号
083001 [环境科学];
摘要
Alcohol use disorders and alcohol dependency affect millions of individuals worldwide. The impact of these facts lies in the elevated social and economic costs. Alcoholic liver disease is caused by acute and chronic exposure to ethanol which promotes oxidative stress and inflammatory response. Chronic consumption of ethanol implies liver steatosis, which is the first morphological change in the liver, followed by liver fibrosis and cirrhosis. This review comprises a broad approach of alcohol use disorders, and a more specific assessment of the pathophysiologic molecular basis, and genetics, as well as clinical presentation and current modalities of treatment for alcoholic liver disease.
引用
收藏
页码:1872 / 1888
页数:17
相关论文
共 49 条
[1]
Noninvasive assessment of fibrosis and steatosis in NASH and ASH [J].
Angulo, P. .
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2009, 33 (10-11) :940-948
[2]
An evaluation of μ-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence [J].
Anton, Raymond F. ;
Oroszi, Gabor ;
O'Malley, Stephanie ;
Couper, David ;
Swift, Robert ;
Pettinati, Helen ;
Goldman, David .
ARCHIVES OF GENERAL PSYCHIATRY, 2008, 65 (02) :135-144
[3]
Efficacy of a Combination of Flumazenil and Gabapentin in the Treatment of Alcohol Dependence Relationship to Alcohol Withdrawal Symptoms [J].
Anton, Raymond F. ;
Myrick, Hugh ;
Baros, Alicia M. ;
Latham, Patricia K. ;
Randall, Patrick K. ;
Wright, Tara M. ;
Stewart, Scott H. ;
Waid, Randy ;
Malcolm, Robert .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2009, 29 (04) :334-342
[4]
Combined pharmacotherapies and behavioral interventions for alcohol dependence - The COMBINE study: A randomized controlled trial [J].
Anton, RF ;
O'Malley, SS ;
Ciraulo, DA ;
Cisler, RA ;
Couper, D ;
Donovan, DM ;
Gastfriend, DR ;
Hosking, JD ;
Johnson, BA ;
LoCastro, JS ;
Longabaugh, R ;
Mason, BJ ;
Mattson, ME ;
Miller, WR ;
Pettinati, HM ;
Randall, CL ;
Swift, R ;
Weiss, RD ;
Williams, LD ;
Zweben, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (17) :2003-2017
[5]
Silencing a killer among us: Ethanol impairs immune surveillance of activated stellate cells by natural killer cells [J].
Arteel, Gavin E. .
GASTROENTEROLOGY, 2008, 134 (01) :351-353
[6]
Treatment of alcoholic liver disease [J].
Bergheim, I ;
McClain, CJ ;
Arteel, GE .
DIGESTIVE DISEASES, 2005, 23 (3-4) :275-284
[7]
Chronic ethanol feeding affects proteasome-interacting proteins [J].
Bousquet-Dubouch, Marie-Pierre ;
Nguen, Sheila ;
Bouyssie, David ;
Burlet-Schiltz, Odile ;
French, Samuel W. ;
Monsarrat, Bernard ;
Bardag-Gorce, Fawzia .
PROTEOMICS, 2009, 9 (13) :3609-3622
[8]
Butterworth RF, 2003, ALCOHOL RES HEALTH, V27, P143
[9]
The impact of CYP2E1 on the development of alcoholic liver disease as studied in a transgenic mouse model [J].
Butura, Angelica ;
Nilsson, Kerstin ;
Morgan, Kengathevy ;
Morgan, Timothy R. ;
French, Samuel W. ;
Johansson, Inger ;
Schuppe-Koistinen, Ina ;
Ingelman-Sundberg, Magnus .
JOURNAL OF HEPATOLOGY, 2009, 50 (03) :572-583
[10]
Effects of alcohol and oxidative stress on liver pathology: The role of the mitochondrion [J].
Cahill, A ;
Cunningham, CC ;
Adachi, M ;
Ishii, H ;
Bailey, SM ;
Fromenty, B ;
Davies, A .
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2002, 26 (06) :907-915